Cerebrospinal Fluid (1,3)-Beta- d -Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis
- 1 November 2016
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 54 (11), 2707-2710
- https://doi.org/10.1128/jcm.01224-16
Abstract
Diagnosing coccidioidal meningitis (CM) can be problematic owing to its infrequency and/or a delay in the positivity of a cerebrospinal fluid (CSF) culture or CSF antibody, particularly if the primary coccidioidal infection is unrecognized. We tested 37 CSF specimens, 26 from patients with confirmed CM and 11 from patients with suspected microbial meningitis without fungal diagnosis, for (1,3)-beta-glucan (BG). BG in CM CSF specimens ranged from 18 to 3,300 pg/ml and in controls ranged from 103 pg/ml were CM. The one false-negative specimen was from a patient with a pseudosyrinx, without inflammatory evidence of meningitis activity. Serial samples from some patients were positive at ≤8 years, indicating no loss of positivity with chronicity. Samples stored frozen since 2000 included those with 2 of the 3 highest values, indicating that fresh samples not required. A previous study indicated serum sensitivities of 53% in acute, 50% in resolved, and 83% in disseminated and meningeal coccidioidomycosis. Three studies of other fungal meningitides ranged from 86 to 1,524 pg/ml CSF, with 37 controls of <4 to 115 pg/ml CSF. CSF BG analysis had good diagnostic performance in CM. CSF BG testing can be useful in CM, and a commercial kit is available. It will be of interest to correlate this with course, treatment, outcome, inflammation, and antigen. The only mycoses with common central nervous system (CNS) involvement are cryptococcal and coccidioidal, so CSF BG screening can be useful in meningitis diagnosis.Keywords
This publication has 26 references indexed in Scilit:
- Specificity of mannan antigen and anti‐mannan antibody screening in patients with haematological malignancies at risk for fungal infectionMycoses, 2016
- A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample sizeStatistical Methods in Medical Research, 2015
- Utility of Measuring (1,3)-β- d -Glucan in Cerebrospinal Fluid for Diagnosis of Fungal Central Nervous System InfectionJournal of Clinical Microbiology, 2015
- Utility of (1–3)-β-d-Glucan Testing for Diagnostics and Monitoring Response to Treatment During the Multistate Outbreak of Fungal Meningitis and Other InfectionsClinical Infectious Diseases, 2013
- Serum (1→3)-β- d -Glucan Measurement in CoccidioidomycosisJournal of Clinical Microbiology, 2012
- Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumoniaClinical Microbiology & Infection, 2012
- Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitisJournal of Antimicrobial Chemotherapy, 2007
- Pharmacokinetics, biological effects, and distribution of (1→3)-β-D-glucan in blood and organs in rabbitsMediators of Inflammation, 1997
- Soluble (1→3)-β-D-glucan purified from Candida albicans: Biologic effects and distribution in blood and organs in rabbitsJournal of Laboratory and Clinical Medicine, 1996
- Serology of coccidioidomycosisClinical Microbiology Reviews, 1990